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Abstract.  Tau protein from mammalian brain pro- 
motes microtubule polymerization in vitro and is in- 
duced during nerve cell differentiation. However, the 
effects of tau or any other microtubule-associated pro- 
tein on tubulin assembly within cells are presently un- 
known. We have tested tau protein activity in vivo by 
microinjection into a  cell type that has no endogenous 
tau protein. Immunofluorescence shows that tau pro- 
tein microinjected into fibroblast cells associates 
specifically with microtubules. The injected tau protein 
increases tubulin polymerization and stabilizes 
microtubules against depolymerization. This increased 
polymerization does not, however, cause major 
changes in cell morphology or microtubule arrange- 
ment. Thus, tau protein acts in vivo primarily to in- 
duce tubulin assembly and stabilize microtubules, ac- 
tivities that may be necessary, but not sufficient, for 
neuronal morphogenesis. 
N 
'EURONAL processes are densely filled with parallel 
arrays of microtubules that act as scaffolds neces- 
sary for process extension (Daniels,  1975; Yamada 
et al., 1976) and serve as tracks for axonal transport (Schnapp 
et al., 1985). Studies using clonal cell lines that extend neu- 
ritic processes in culture have shown that neurite extension 
involves net microtubule assembly,  and not simply rear- 
rangement of existing microtubules into growing processes 
(Drubin et al.,  1985; Gard et al.,  1985; Olmstead,  1981). 
Microtubule assembly during neuronal process extension 
appears to involve the recruitment of tubulin from preexist- 
ing monomer pools  into tubulin polymers (microtubules) 
(Drubin et al.,  1985; Gard et al.,  1985; Olmsted, 1981). It 
has been proposed that this assembly is driven by nontubulin 
protein factors that accumulate during process  extension. 
Support for this proposal comes from the observation that 
extracts from mature rat brain tissue and from differentiated 
neuroblastoma ceils contain higher levels of protein factors 
that promote microtubule assembly than do extracts from 
their respective  less-differentiated counterparts (Nunez  et 
al.,  1975; Seeds and Maccioni, 1978). 
Three major protein factors that promote microtubule as- 
sembly in vitro have been identified in brain extracts. These 
include the tau proteins of 50-70 kD (Weingarten et al., 1975; 
Cleveland et al.,  1977), microtubule-associated protein  1 
(MAP1) ~ of '~330 kD, and microtubule-associated protein 
2 (MAP2) of "~300 kD (for a review of MAP1  and MAP2 
see Vallee et al.,  1984). During neurite extension in PC12 
pheochromocytoma cells, levels of tau protein correlate pre- 
cisely with levels of assembled tubulin (Drubin et al., 1985). 
Furthermore, tau protein is bound to microtubules in PC12 
cells (Drubin et al., 1986). These observations make tau pro- 
1. Abbreviations  used in this paper: MAP1 and MAP2, microtubule-associ- 
ated proteins 1 and 2. 
tein a strong candidate for a factor that promotes microtubule 
assembly during process extension. Still, given the complex 
function that microtubules serve, it is not clear which associ- 
ated proteins regulate polymer assembly and which regulate 
the interaction of microtubules with other components in the 
cell or serve some other function. Subtle questions about the 
importance of microtubule-associated proteins for polymer 
stability and dynamics have not been addressed in an in vivo 
context. 
To test the activity of tau protein in vivo we have microin- 
jected purified tau protein into living fibroblast cells (RATI) 
that normally contain undetectable levels of this factor. Im- 
munofluorescence shows that microinjected tau protein binds 
specifically  to  microtubules  (Drubin  et  al.,  1985). Two 
effects  were demonstrated:  first,  tau  causes a  marked in- 
crease in the level of assembled tubulin. Even more dramati- 
cally tau protein increases both centrosome-nucleated and 
nonnucleated assembly in cells treated with low levels  of 
microtubule  depolymerizing  drugs.  Second,  tau  protein 
decreases the depolymerization rate of microtubules. These 
observations  support the conclusion that tau protein pro- 
motes the assembly of microtubules that is required for neu- 
ronal process extension, and additionally stabilizes the re- 
suiting polymers. 
Materials and Methods 
Cell Culture and Microinjections 
RAT1 fibroblast cells were cultured in DME supplemented with 10% calf 
serum (Gibco, Grand Island, NY).  For microinjection experiments, cells 
were trypsinized and replated on poly-D-lysine coated coverslips. To com- 
pare microinjected cells with control sister cells, single cells were plated 
at low density ,,o15 h before microinjection. This allowed many cells time 
to divide once, often resulting in pairs of associated sister cells with similar 
morphologies. Micruinjections were carried out exactly as described by 
Schulze and Kirschner (1986). 
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The Journal of Cell Biology, Volume 103 (No. 6, Pt. 2), Dec. 1986  2739-2746  2739 Figure 1. Localization of microinjected tau protein on RAT1 microtubules by double-label immunofluorescence. (A) Rhodamine antitubulin 
staining showing micmtubule networks in RATI cells fixed 40 min after one cell (arrow) was microinjected with 2  mg/ml bovine brain 
tau protein.  (B) Fluorescein anti-tau staining showing tau localization on microtubules in the tau-micminjected cells, and absence of tan 
in the uninjected cells shown in A.  Bar,  10  p.m. 
Protein Preparation 
FITC-BSA was obtained from Sigma Chemical Co., (St. Louis, MO). Bo- 
vine brain tau protein was separated from MAP2 in heat-stable microtubule- 
associated proteins by chromatography on Sepharose 4BCL (Pharmacia 
Fine Chemicals, Piscataway,  NJ) as described in detail in Herzog and We- 
ber, 1978, and was concentrated using an ultrafiltration unit (Amicon Corp., 
Danvers, MA). 
microtubule lengths were digitized by projecting images from negatives onto 
a GITCO (Rockville, MD) digitizing pad interfaced with an IBM personal 
computer. For cells with more dense microtubule arrays (cells treated for 
<30 min with 33  ~tM nocodazole) relative microtubule mass was deter- 
mined by densitometry of  negatives containing images of  mitotic sister cells 
using a  Zeinet soft laser densitometer (Biomed Instruments, Inc.,  Chi- 
cago, IL). 
Immunofluorescence 
Cells were washed briefly with PBS (0.13 M  NaC1,  2  mM KCI,  8  mM 
NazHPO4, 2 mM KH2PO4, pH 7.2) and then immersed for 10 min at room 
temperature in 80 mM Pipes, pH 6.8, 5 mM EGTA, 1 mM MgC12, and the 
detergent 1%  Empigen BB (Albright and Wilson, Whitehaven, Cumbria, 
UK), 0.3% glutaraldehyde. The cells were next rinsed briefly in PBS and 
then incubated in PBS containing 1 mg/ml NaBI-h for 7 min. Before and 
after each antibody addition the cells were washed five times in PBS con- 
raining 1% BSA and 0.1% Tween 20 over a 10-rain period. Antibodies were 
diluted in this same wash buffer. For double-label immunofluorescence, 
fixed and permeabilized cells were treated for 30 min with affinity-purified 
anti-bovine brain tau protein antiserum (Drubin et al., 1984; Pfeffer et al., 
1983) (1:200 dilution), for 15 min with DMct-I tubulin monoclonal antibody 
(Blose et al., 1984) (1:2,000 dilution, a gift of  Dr. Steven Blose, Cold Spring 
Harbor  Laboratory,  Cold  Spring  Harbor,  NY),  and  for  15  min  with a 
mixture of fluorescein-conjugated goat anti-rabbit antiserum and rhoda- 
mine-conjugated goat  anti-mouse  antiserum  (1:50  and  1:200  dilution, 
respectively). Coverslips were mounted in 90%  vol/vol glycerol, 20 mM 
Tris pH 7.9. 
Microinjected cells were identified using a fluorescein filter. Cells were 
photographed on  hypersensitized Kodak Tech-Pan (2415) film using the 
fluorescein filter  as  described by  Schulze and  Kirschner (1986).  After 
bleaching the fluorescein image for several minutes to eliminate possible 
effects of"bleed through" of  the fluorescein signal into the rhodamine chan- 
nel, the tubulin staining pattern was photographed using a rhodamine filter. 
Microtubule Quantitation 
Relative microtubule mass in sister cells with similar morphologies was 
quantitated  in  two  ways.  For cells treated 30  min  in  nocodazole, total 
Results 
Microinjected  Tau Protein Binds Specifically to 
Microtubules in Living Cells 
The antitubulin immunofluorescent staining pattern of a field 
of RAT1 fibroblast cells is shown in Fig. 1 A. The cell desig- 
nated by an arrow was microinjected with a 2 mg/ml solution 
of purified bovine brain tau protein to '~10 % the cell volume 
40 min before fixation. (Tau protein was purified from bovine 
brain to give the usual four major subspecies by the proce- 
dure of Drubin and Kirschner [1986] based on the method 
of Herzog and Weber [1978]). The anti-tau immunofluores- 
cent staining pattern of the same field of cells shown in Fig. 
1 A is shown in Fig. 1 B. The three uninjected cells are devoid 
of tau immunofluorescence even though the affinity-purified 
tau antiserum employed in these studies binds tightly to tau 
protein isolated from rat PC12 cells (Drubin et al., 1985) and 
brain. The cell microinjected with tau protein, on the other 
hand, is stained brightly by the affinity-purified tau antibody. 
The tau staining pattern in the microinjected cell is identical 
to the corresponding tubulin staining pattern shown in Fig. 
1 A. We conclude that the microinjected tau protein is bound 
to microtubules in RATI cells, a result further supported by 
the observation that pretreatment of the cells with drugs in- 
The Journal  of Cell Biology,  Volume 103, 1986  2740 Figure 2. Affect of microinjected tau protein on microtubule assembly in RAT1 cells. (A) Rhodamine antitubulin staining of RAT1 sister 
cells fixed •40  min after one cell (arrow) was microinjected with 2 mg/ml FITC-BSA. (B) Fluorescein fluorescence showing FITC-BSA 
presence in the microinjected cell shown in A. (C) Rhodamine antitubulin staining of RAT1 sister cells fixed ,x,40 min after one cell (arrow) 
was microinjected with 2 mg/ml bovine brain tau protein.  (D) Fluorescein  anti-tau staining showing tau localization on microtubules  in 
tau-microinjected  cell shown in C. Bar,  10 I.tm. 
hibiting tubulin polymerization abolishes the filamentous tau 
immunofluorescence pattern (not shown). The fixation pro- 
cedure preserves all known elements of the cytoskeleton, and 
in no case was tau staining observed in association with any 
structures other than microtubules. 
Tau Protein Promotes Microtubule Assembly in 
Fibroblast Cells 
The ability to introduce tau protein into living RAT1  cells 
that normally lack this factor makes possible an evaluation 
of the in vivo effects of tau protein on microtubule assembly 
and microtubule stability. Immunofluorescence results like 
that shown in Fig.  1 A usually give the impression that cells 
microinjected with tau  protein contain higher microtubule 
densities than uninjected neighboring cells. The possible ex- 
tent  of an  increase  in  microtubule  density  caused  by  tau 
microinjection ultimately is limited by the size of the unas- 
sembled tubulin pool. Estimates for the proportion of tubulin 
in the unassembled state range from 10-50% (Hiller and We- 
ber,  1978; Caron et al.,  1985). 
We have used two approaches to further study the effects 
of microinjected tau protein on the extent of microtubule as- 
sembly in RAT1 cells. In both approaches one cell in a pair 
of mitotic sister ceils was microinjected with tau protein and 
the microtubule arrays in both cells were compared by im- 
munofluorescence. Sister cells were used because they have 
similar morphologies (Solomon, 1981) and similar microtu- 
bule patterns (Fig. 2 A). We have noted that with this cell line 
comparisons between  sister cells are much more accurate 
than general population comparisons. For the first strategy, 
normal  RAT1  sister  cells  were examined.  For the  second 
strategy, the pool of unassembled tubulin was artificially in- 
creased by incubating the cells in nocodazole. This increases 
the maximum possible augmentation in assembled tubulin 
that can be achieved by tau microinjection, and thus provides 
an opportunity for a more dramatic visualization of the effect 
of tau protein.  In both cases a  2  mg/ml tau microinjection 
concentration was employed to create a tau-to-tubulin molar 
ratio in RAT1 cells similar to that found in PC12 cells after 
tau induction during neurite extension (assuming that  10% 
of a cell volume can be microinjected and that a cell contains 
2 mg/ml tubulin) (Hiller and Weber,  1978). As a control for 
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Figure 3. (A) Histogram show- 
ing the distribution of micro- 
tubule  mass  ratios  between 
cells microinjected with FITC- 
BSA, and their respective sis- 
ter cells. The arrow indicates 
the  interval  containing  the 
arithmetic  mean, and the as- 
terisk shows the interval into 
which the cell pair in 2 A fell. 
(B) Histogram showing the dis- 
tribution of microtubule mass 
ratios between cells microin- 
jected  with  bovine brain  tan  protein,  and  their respective  sister 
cells.  The arrow indicates the  interval containing  the arithmetic 
mean, and the asterisk shows the interval into which the cell pair 
in 2 C fell. 
the comparison of microtubule densities in sister cells either 
microinjected or not injected with tau protein, cells were in- 
jected with 2  mg/ml FITC-BSA. 
Fig. 2 A shows a pair of RAT1 sister cells with similar mor- 
phologies and microtubule distributions. The cell indicated 
with an arrow was microinjected with 2 mg/ml FITC-BSA 
40 min before fixation (see Fig. 2 B for FITC-BSA fluores- 
cence).  No noticeable difference in microtubule density is 
apparent in  comparing the cell microinjected  with  FITC- 
BSA to the uninje~ted cell. For twelve pairs of sister cells the 
ratios of microtubule mass in cells receiving or not receiving 
BSA, as determined by densitometry, are shown in the histo- 
gram in Fig. 3 A. The distribution ranges from 0.6 to 1.6 with 
an arithmetical mean (arrow, and first line of Table I) of 0.96 
+  0.09. The position of the ratio determined for the cell pair 
shown in Fig.  2 A is shown with an asterisk. 
Fig. 2 C shows another pair of sister RATI cells. The cell 
designated with an arrow was microinjected with 2 mg/ml 
tau protein 40 min before fixation (see Fig. 2 D  for tau im- 
munofluorescence). In this case, as was the case in Fig.  1 A, 
the microinjected cell appears to have a higher microtubule 
density than its sister cell. The histogram in Fig. 3 B shows 
the microtubule density ratios for 16 cells containing tau and 
their sisters lacking tau. The distribution ranges from 1.0 to 
2.1  with the arithmetical mean at 1.44  +  0.08  (arrow, and 
first line in Table I). The position of the ratio determined for 
the cell pair shown in Fig. 2 C is designated by an asterisk. 
Table L Microtubule Assembly and Stability in 
RAT1 Cells Microinjected with Tau Protein 
Tau  FITC-BSA 
Time  in 33 gM  Microtubule mass*  Microtubule mass 
nocodazole  (injected/noninjected)  n  (injected/noninjected)  n 
rain 
0  1.44  +  0.08¢  16  0.96  +  0.09  12 
1  4.29  +  0.59  15  1.10  +  0.30  8 
3.5  2.82  +  0.46  11  1.23  +  0.19  11 
12  2.99  +  0.43  11  -  - 
30  1.95  +  0.40  10  1.06  +  0.40  7 
* Microtubule mass ratios for pairs of sister cells, one of which was microin- 
jected  with tau protein or BSA  before drug treatment,  were determined as 
detailed in Materials and Methods. 
¢ Standard error equals the standard deviation/~/-n. 
The  difference between  0.96  +  0.09  and  1.44  +  0.08  is 
statistically significant using a Student's t test to <0.005. We 
conclude that microinjected tan protein causes, on the aver- 
age, an approximate 44% increase in microtubule assembly 
iri RAT1  cells. 
To produce a more dramatic effect oftau protein on micro- 
tubule assembly in vivo, the following protocol was used. 
One cell in each pair of sister cells was microinjected with 
either tau protein or FITC-BSA. 30 min later the cells were 
treated for 35 min with 33 gM nocodazole to eliminate vir- 
tually  all  microtubules  from RAT1  cells,  whether  or  not 
they  have been microinjected  with  tau protein.  Next,  the 
nocodazole concentration was reduced to 0.4 gM for 1 or 
2 h. Under these conditions most of the tubulin in each cell 
remains  unassembled,  but  limited  microtubule  assembly 
occurs. 
When sister cells were treated as described above the cells 
microinjected with tau protein invariably had dense astral ar- 
rays of microtubules as well as microtubule fragments ir- 
respective of whether they were incubated for 1 h (Fig. 4 A, 
arrow) or 2 h (Fig. 4 B, arrow) in 0.4 gM nocodazole, while 
astral microtubules were absent from ceils not microinjected 
with tau. Furthermore, the cells microinjected with tau pro- 
tein  contained longer  microtubules and  apparently higher 
densities of free microtubules than their uninjected counter- 
parts. The consistency of this affect between cells treated for 
1 h and cells treated for 2 h with 0.4 I~M nocodazole suggests 
that this is a steady state phenomenon.  Microinjection of 2 
mg/ml FITC-BSA did not affect microtubule assembly under 
these conditions (not shown). 
Tau Protein Stabilizes Cellular Microtubules 
An expectation arising from the demonstration that tau pro- 
tein promotes microtubule assembly in vivo is that microtu- 
bules coated with tau protein in RAT1 cells will be more sta- 
ble than those without tau protein. Microtubule stability can 
be evaluated operationally by incubating cells in high levels 
of nocodazole, a drug blocking microtubule assembly (Sal- 
mon et al.,  1984).  For these experiments RAT1  cells were 
microinjected with 2 mg/ml tau protein or 2  mg/ml FITC- 
BSA, and were treated 60 min later with 33 gM nocodazole 
for the times indicated below. 
The cell marked with an arrow in Fig.  5 A was micro- 
injected  with  2  mg/ml FITC-BSA (see  Fig.  5  B  for BSA 
fluorescence) and treated for 1 min with 33 ~M nocodazole. 
The microtubule networks in both cells shown in Fig.  5 A 
have been greatly thinned compared with cells not exposed 
to nocodazole. Generally the majority of microtubules disap- 
pears within 1 min of treatment with nocodazole and the re- 
maining microtubules disappear more slowly over the next 
30-40 min. Microinjection of 2 mg/ml FITC-BSA into the 
RAT1  cell  shown in  Fig.  5  A  did  not affect the  extent of 
microtubule disappearance after 1 min with nocodazole as 
compared with the neighboring uninjected cell. The cell in- 
dicated with an arrow in Fig.  5  C, however, was microin- 
jected  with  2  mg/ml  of tau  protein  and  then  exposed  to 
nocodazole for 1 min (see Fig. 5 D  for tau immunofluores- 
cence).  While  the microtubule networks  in  the  two unin- 
jected cells have been dramatically thinned by nocodazole 
treatment, the microtubule network in the tau-containing cell 
seems unaffected by nocodazole. 
To determine whether tau protein blocks microtubule dis- 
The Journal of Ceil Biology, Volume  103,  1986  2742 Figure 4. Promotion of  microtubule assembly by microinjected tau protein in nocodazole-treated RATI cells. Rhodamine antitubulin staining 
of sister RAT1 cells of which one cell (arrow) was microinjected with 2 mg/ml tau protein 30 min before a 35-min 33 ltM nocodazole 
treatment followed by 1-h (A) or 2-h (B) treatment with 0.4 I~M nocodazole. Bar, 10 Ixm. 
assembly  completely or  alternatively  slows  the  process, 
longer nocodazole treatment times were employed. Fig.  6 
shows pairs of sister cells treated for different times with 33 
lxM nocodazole. In each case the cell microinjected with 2 
mg/ml tau protein is designated with an arrow. After 1 rain 
of nocodazole treatment (Fig. 6 A, as was shown for the cells 
in Fig. 5 C), the cell containing tau protein has a significantly 
higher density of microtubules than the cell without tau. 
After 3.5 min (Fig. 6 B) of nocodazole treatment a slight de- 
crease in microtubule density is now apparent in the micro- 
injected cell, especially toward the interior of the cell. Fi- 
naUy, after 30 min of nocodazole treatment (Fig.  6  C) the 
tau-microinjected cell has a greatly reduced microtubule net- 
work, although more microtubules remain in the microin- 
jected cell than in the neighboring uninjected cell. Eventu- 
ally virtually all microtubules disappear from microinjected 
and uninjected cells (not shown). Thus, tau protein slows that 
rate of disassembly but does not fully inhibit tubulin dissoci- 
ation. 
For nocodazole-treated pairs of cells the ratio of microtu- 
bule mass in microinjected vs. uninjected sisters was deter- 
mined roughly by densitometry for time points at which a 
large number of microtubules are present. When the number 
of microtubules was small, microtubule mass was accurately 
determined by digitometry of total microtubule length. Table 
I  shows  the  average ratios of microinjected to  uninjected 
microtubule mass for pairs of sister cells. The difference is 
largest after 1 min of nocodazole treatment, when most of 
the RATI cell microtubules are lost. At this time four times 
as much microtubule mass remains in cells containing tau 
than remains in uninjected cells. Again, FITC-BSA has no 
affect on microtubule retention. At 3.5 and 12 min of  nocoda- 
zole treatment, a further reduction in the microtubule net- 
works is seen in both ceils.  However this still leaves three 
times  as  much  tubulin  in  the  polymerized state  in  tau- 
containing cells. Lastly, at 30 min (Fig. 6 C) there still re- 
mains twice as much tubulin in cells containing tau than re- 
mains in uninjected cells or cells containing FITC-BSA. 
Discussion 
Tau protein was originally defined biochemically as a factor 
that coassembled with tubulin and promoted microtubule as- 
sembly in vitro (Weingarten et al.,  1975; Cleveland et al., 
1977). It was later shown to be rather specific to neuronal 
cells  and  to  be  associated  with  microtubules  in  neuritic 
processes by immunofluorescence (Drubin et al.,  1986).  In 
brain, tau is preferentially localized in axons rather than in 
dendrites or cell bodies (Binder et al.,  1985;  Peng et al., 
1986), but in certain brain pathologies, such as Alzheimer's 
disease, it can be found in unusual structures called neuro- 
fibrillary tangles  (Wood et al.,  1986;  Kosik et  al.,  1986; 
Grundke-Iqbal et al., 1986). Despite the evidence for a close 
association of tau  protein with microtubules,  the difficult 
histochemistry and the high density of microtubules in neu- 
ronal cells made it difficult to assess whether tau protein was 
also associated with other major cytoskeletal elements such 
as intermediate filaments or actin filaments.  Such possible 
associations  have  been  inferred  by  in  vitro  experiments 
(Carlier et al., 1984; Seldon and Pollard, 1983; Runge et al., 
Drubin and Kirschner  Tau Protein  Function  in Living  Cells  2743 Figure 5.  Stabilization of RAT1 microtubules by microinjected tau protein.  (A) Rhodamine antitubulin staining of RAT1 cells treated for 
1 min with 33 IxM nocodazole 60 min after one cell (arrow) was microinjected with FITC-BSA. (B) Fluorescein  fluorescence showing 
FITC-BSA presence in the microinjected cell shown in A. (C) Rhodamine antitubulin staining of RATI cells treated for 1 min with 33 
~tM nocodazole 60 min after one cell (arrow) was microinjected with 2 mg/ml bovine brain tau protein.  (D) Fluorescein anti-tau staining 
showing tau localization on microtubules  in the tau-microinjected cell shown in C. Bar, 10 I.tm. 
1979) and could also play a role in pathological conditions. 
However, as shown here, when tau protein is injected into 
fibroblast  cells,  it  associates primarily  with  microtubules 
and not actin or intermediate filaments. It is possible that in 
neuronal cells specific proteins could mediate its interaction 
with other components of the cytoskeleton. No preference is 
shown for any subsets of microtubules in the cell. 
The importance of tau  as an assembly-promoting factor 
rests on its in vitro activity, which it shares with other as- 
sociated proteins,  and circumstantially, on its induction  by 
nerve growth factor in pheochromocytoma cells at the time 
of neurite extension (Drubin et al.,  1985).  In the absence of 
a specific drug for inhibiting tau activity, the best test for tau 
function would be to genetically or pseudogenetically alter 
tau expression.  We have chosen to use fibroblast cells be- 
cause of the low or absent basal level of tau expression, and 
because of the favorable morphology which allows a  semi- 
quantitative assessment of the degree of microtubule assem- 
bly. We have, in effect, performed a complementation experi- 
ment to study tau function in vivo. Starting with fibroblast 
cells that contain undetectable levels of tau protein, tau pro- 
tein was microinjected at physiological levels (similar to the 
levels in PC12 cells after treatment with nerve growth factor 
(Drubin et al.,  1985)  and effects on microtubule assembly 
were examined. 
As shown in Table I, injected tau protein increases micro- 
tubule levels in RAT1 fibroblast cells by an average of 44% 
over levels found in morphologically similar sister cells. The 
magnitude of this assembly induction,  though small, could 
be limited by the pool of available tubulin. In PC12 cells the 
pool of available tubulin increases before tau induction and 
thus  the  tau  induction  can  produce  a  larger  increase  in 
microtubule assembly (Drubin et al.,  1985).  To observe a 
more dramatic tan effect in  RATI  cells,  we artificially in- 
creased the pool of unassembled tubulin by nocodazole treat- 
ment. When tau protein was injected into cells subsequently 
The Journal of Cell Biology, Volume  103, 1986  2744 Figure 6. Retardation of nocodazole-induced microtubule disassembly in RAT1 ceils containing microinjected tau protein. Rhodamine an- 
titubulin staining of sister RAT1 cells of which one cell (arrow)  was microinjected with 2 mg/ml tau protein ~60 rnin before the addition 
of 33 ~tM nocodazole for 1 min (A), 3.5  min (B),  or 30 min (C). Bar,  10 Ixm. 
treated with nocodazole, we observed a dramatic increase in 
assembly as compared with uninjected controls. Increases in 
microtubule  length  and  in  the  number of astral  and  free 
microtubules were observed. The apparent promotion of free 
microtubule formation in response to tau microinjection sug- 
gests that tau presence in axons could promote centrosome- 
independent microtubule assembly predicted by electron mi- 
croscopic  studies  (Chalfie  and  Thomson,  1979; Bray  and 
Bunge,  1981). 
While  tau  protein  promotes  microtubule  assembly  in 
RAT1 cells, it does not cause obvious morphological changes 
over the  3-h time course examined  (beyond 3  h,  microin- 
jected tau protein cannot be detected by immunofluorescence 
due, presumably, to protein degradation).  Therefore, while 
neurite extension requires microtubule assembly, increased 
microtubule assembly is not sufficient to cause neurite exten- 
sion.  Additional  factors must be required  to utilize  newly 
formed microtubules for process extension.  While tau pro- 
tein microinjection failed to induce a  neuritic morphology, 
it  did  show  that  this  factor  can  promote  the  increased 
microtubule assembly observed during nerve growth factor- 
induced  morphogenesis. 
Consequences of Tau Binding for 
Microtubule Dynamics 
The presence of tau protein on microtubules in RAT1 cells 
reduces drastically the apparent dissociation rate of tubulin 
from microtubules as judged by the procedure of Salmon et 
al.,  1984,  in which cells are incubated in very high concen- 
trations  of nocodazole.  When  we  examined  the  effect of 
microinjected tau protein, microtubules containing tau pro- 
tein were found to depolymerize more slowly in response to 
high concentrations of nocodazole (Fig.  5  and 6,  Table I). 
This result suggests that the  increased  stability of neuritic 
microtubules in differentiated PCI2 cells (Black and Greene, 
1982; Heideman et al.,  1985) is at least partially due to the 
presence of tau protein. 
The disappearance of microtubules from normal fibroblast 
cells treated with high nocodazole levels (Fig. 5 and 6) does 
not  appear  to  occur  by  a  progressive  shortening  of  all 
microtubules from the cell periphery toward the centrosome. 
Instead,  the  number of microtubules  decreases  with  time 
without  evidence  for disassembly intermediates.  This be- 
havior was also observed recently in monocytes in which it 
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(Cassimeris et al.,  1986).  In monocytes and in fibroblasts 
most microtubules are lost quickly in response to nocodazole 
treatment but a  subset of mierotubules is lost at a signifi- 
cantly slower rate. The rate-limiting step appears to be initia- 
tion of  depolymerization, not dissociation of  tubulin subunlts 
from depolymerizing microtubules. These observations can 
be explained if the disappearance of microtubules in fibro- 
blast cells results from a transition from a stable or growing 
state to a rapidly shrinking state, as suggested by the model 
of dynamic instability (Mitchison and Kirschner,  1984). 
Tan protein slows the rate of microtubule loss without al- 
lowing visualization of disassembly intermediates. Thus it 
appears  that tau  stabilizes microtubules primarily by de- 
creasing the transition rate to the rapidly disassembling state. 
Recent in vitro studies have in fact shown that microtubule- 
associated proteins can have an inhibitory effect on such tran- 
sitions (Horio and Hotani, 1986). 
The fact that tau protein microinjection into growing RATI 
cells causes a significant increase in microtubule assembly 
and stability suggests that these cells normally lack tau-like 
factors at levels found in differentiated PC12 cells. Thus it 
may be that tau-like factors are characteristic of neuronal 
cells that have adopted a differentiated morphology. In sup- 
port of this, assembly behavior of microtubules in fibroblast 
cells (Schulze and Kirschner, 1986) is similar to that found 
in vitro with tubulin lacking associated proteins (Mitchison 
and Kirschner, 1984). Unfortunately we know nothing about 
the presence of MAP proteins in RAT-1 cells. The subset of 
microtubules  in  monocytes and  fibroblasts  that have  in- 
creased stability could, however,  contain selectively bound 
tan-like factors. General lack of tau-like factors in proliferat- 
ing fibroblast cells may explain why only tubulin mutants 
have been obtained when attempts were made to genetically 
identify drug resistant cells in culture. 
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